However, plasma metabolomic analysis in EGFR-mutated NSCLC remains limited, especially in Asian populations such as Thais, where mutation frequencies and metabolic phenotypes may differ from Western cohorts. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.